AU1176299A - Tryptase inhibitors comprising heterocyclic amide compounds - Google Patents

Tryptase inhibitors comprising heterocyclic amide compounds

Info

Publication number
AU1176299A
AU1176299A AU11762/99A AU1176299A AU1176299A AU 1176299 A AU1176299 A AU 1176299A AU 11762/99 A AU11762/99 A AU 11762/99A AU 1176299 A AU1176299 A AU 1176299A AU 1176299 A AU1176299 A AU 1176299A
Authority
AU
Australia
Prior art keywords
amide compounds
heterocyclic amide
tryptase inhibitors
tryptase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11762/99A
Inventor
Takashi Imagawa
Shigeki Kuwahara
Koji Naito
Youichiro Naito
Shinichiro Ono
Hiroshi Sakashita
Masahiro Takeuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of AU1176299A publication Critical patent/AU1176299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
AU11762/99A 1997-11-26 1998-11-24 Tryptase inhibitors comprising heterocyclic amide compounds Abandoned AU1176299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP32503597 1997-11-26
JP9-325035 1997-11-26
PCT/JP1998/005280 WO1999026925A1 (en) 1997-11-26 1998-11-24 Tryptase inhibitors comprising heterocyclic amide compounds

Publications (1)

Publication Number Publication Date
AU1176299A true AU1176299A (en) 1999-06-15

Family

ID=18172430

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11762/99A Abandoned AU1176299A (en) 1997-11-26 1998-11-24 Tryptase inhibitors comprising heterocyclic amide compounds

Country Status (2)

Country Link
AU (1) AU1176299A (en)
WO (1) WO1999026925A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221914B1 (en) 1997-11-10 2001-04-24 Array Biopharma Inc. Sulfonamide bridging compounds that inhibit tryptase activity
CN1550232A (en) 1998-03-11 2004-12-01 Use of heterocyclic amide in production of autoimmune diseases inhibitors
IL144577A0 (en) 1999-01-27 2002-05-23 Ortho Mcneil Pharm Inc Peptidyl heterocyclic ketones useful as tryptase inhibitors
AU2001264077B2 (en) * 2000-06-13 2006-08-10 Tularik Limited Serine protease inhibitors
BR0207730A (en) * 2001-03-02 2004-03-23 Hoffmann La Roche Alkoxycarbonyl-minoheteroaryl carboxylic acid derivatives as ip antagonists
CA2836511C (en) 2011-06-02 2021-10-19 SOCPRA Sciences Sante et Humaines S.E.C. Matriptase inhibitors and uses thereof against orthomyxoviridae infections
US9758473B2 (en) 2014-10-06 2017-09-12 Cortexyme, Inc. Inhibitors of lysine gingipain
WO2017083433A1 (en) 2015-11-09 2017-05-18 Cortexyme, Inc. Inhibitors of arginine gingipain
WO2018053353A1 (en) 2016-09-16 2018-03-22 Cortexyme, Inc. Ketone inhibitors of lysine gingipain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ263084A (en) * 1993-03-12 1997-08-22 Arris Pharm Corp Dipeptide derivatives, treatment of immunomediated inflammatory disorders
SK282537B6 (en) * 1993-03-12 2002-10-08 Axys Pharmaceuticals, Inc. Tryptase inhibitor and its pharmaceutically acceptable salt, phar maceutical preparation containing it and its use
ATE189211T1 (en) * 1994-06-01 2000-02-15 Axys Pharm Inc COMPOSITIONS AND METHODS FOR TREATING DISEASES CAUSED BY MAST CELLS
WO1996030396A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS

Also Published As

Publication number Publication date
WO1999026925A1 (en) 1999-06-03

Similar Documents

Publication Publication Date Title
EP1001764A4 (en) Heterocyclic amide compounds as cell adhesion inhibitors
HK1067124A1 (en) 2-phenyl-substituited imidazotriazinones as phoshodiesterase inhibitors
IL128662A0 (en) Heterocyclic metalloprotease inhibitors
PL338259A1 (en) Novel spiroazabicyclic heterocyclic compounds
PL331795A1 (en) Heterocyclic metaloprotease inhibitors
GB9715892D0 (en) Heterocyclic compounds
IL132170A0 (en) Novel heterocyclic compounds
AU8059598A (en) Heterocyclic amide compounds as cell adhesion inhibitors
AUPP003197A0 (en) New heterocyclic compounds
AU7907498A (en) Novel heterocyclic compounds
AU5619400A (en) Statine-derived tetrapeptide inhibitors of beta-secretase
AU7907298A (en) Novel heterocyclic compounds
AU2723099A (en) Tryptase inhibitors
AU1176299A (en) Tryptase inhibitors comprising heterocyclic amide compounds
AU6291098A (en) Novel heterocyclic compounds
AU8997498A (en) Tryptase inhibitor
GB9706294D0 (en) Heterocyclic compound
AU5999698A (en) Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
AUPO622597A0 (en) New heterocyclic compounds
AUPQ319899A0 (en) Amide compounds
AUPO527597A0 (en) Novel heterocyclic compounds
AUPQ142599A0 (en) New amide compounds
ZA985448B (en) Novel heterocyclic compounds
PL336639A1 (en) Novel heterocyclic compounds
AU8731798A (en) Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase